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Abstract: Loss to follow-up and missing outcomes data are important issues for longitudinal 
observational studies and clinical trials in traumatic brain injury. One popular solution to 
missing 6-month outcomes has been to use the last observation carry forward (LOCF). The 
purpose of the current study was to compare the performance of model-based single-impu-
tation methods with that of the LOCF approach. We hypothesized that model-based meth-
ods would perform better as they potentially make better use of available outcome data. The 
CENTER-TBI study (n = 4509) included longitudinal outcome collection at 2 weeks, 3 
months, 6 months, and 12 months post injury; a total of 8185 GOSe observations were in-
cluded in the database. We compared single imputation of 6-month outcomes using LOCF, 
a MI panel imputation, mixed effect model, a Gaussian process regression, and a multi-state 
model. Model performance was assessed via cross-validation on the subset of individuals 
with a valid GOSe value within 180 +/- 14 days post-injury (n = 1083). All models were fit on 
the entire available data after removing the 180 +/- 14 days post-injury observations from the 
respective test fold. The LOCF method showed lower accuracy (i.e. poorer agreement be-
tween imputed and observed values) than model-based methods of imputation, and showed 
a strong negative bias (i.e. it imputed lower than observed outcomes). Accuracy and bias for 
the model-based approaches were similar to one another, with the multi-state model having 
the best overall performance. All methods of imputation showed variation across different 
outcome categories, with better performance for more frequent outcomes. We conclude that 
model-based methods of single imputation have substantial performance advantages over 
LOCF in addition to providing more complete outcome data. 
 





Assessments of global functional outcome such as the Glasgow Outcome Scale (GOS) and 
the Glasgow Outcome Scale extended (GOSe) are used across the full spectrum of recov-
ery, and have popularity as endpoints in traumatic brain injury.1,2 However, missing outcome 
data is a common problem in TBI research, and for longitudinal studies completion rates at 
six months can be lower than 70%.3 This is important, since complete-case analyses may 
introduce bias and at least reduce power. 4 
Last observation carried forward (LOCF) is a recommended single-imputation method for 
dealing with missing data in TBI research clinical trials because it is conservative with re-
spect to evaluation of the intervention.5 One recognized version of this approach is to substi-
tute the three-month outcome for missing six-months data.6,7 Although LOCF is easy to un-
derstand and implement, the technique is suboptimal in several respects. Firstly, it is biased 
in that it ignores potential time trends in GOS(e) trajectories. Secondly, application of LOCF 
is inefficient, since it neglects data observed briefly after the target time window. For exam-
ple, a GOS(e) value recorded at 200 days post-injury is likely to be more informative about 
the status at 180 days post-injury than a value observed 90 days post-injury. Finally, the ad-
hoc nature of the LOCF method implies that there is no probabilistic model, and thus no 
measure of uncertainty concerning the imputed values. This also implies that it is impossible 
to include additional covariates to further reduce bias introduced by the imputation method 
and that LOCF cannot be used to obtain multiply imputed data sets by design. Statistical Im-
putation of patient outcomes is gradually gaining acceptance in the TBI field as a method of 
dealing with missing data. Recent longitudinal studies have successfully employed tech-
niques for both single6,8,9 and multiple imputation.10–13 
Model-based imputation may not only be of value in case of missing outcomes, but also for 
dealing with effects of broad time windows for assessments. The variation in timing of out-
come assessments for patients with TBI varies between studies. Some studies define very 
 
 
stringent time windows (e.g. +/- 2 weeks; https://tracktbi.ucsf.edu/researchers), but in some 
contexts this can lead to a substantial amount of missing data).3 Consequently other studies 
have defined more pragmatic protocol windows (e.g. -1 month to +2 months, see also14). 
While the wider windows enable more complete data collection, they suffer from the problem 
that outcome can be evolving over this period, and an outcome assessment obtained at five 
months (the beginning of this window) in one subject may not be strictly comparable with 
outcomes obtained just before eight months (the end of the window) in another subject. Con-
sequently, even where outcomes are available within pragmatic protocol windows, there 
may be a benefit from being able to impute an outcome more precisely at the 180 day (6 
month) time point. 
In this manuscript, four model-based imputation strategies for GOSe at 6 months (=180 
days) post-injury in the longitudinal CENTER-TBI study14 are compared with LOCF with re-
spect to their single-imputation performance. The focus on single-imputation is due to the 
fact that the imputed values are to be integrated in the CENTER-TBI database and used in 
subsequent analyses by investigators. We examine four different model-based approaches 
– a panel imputation approach using multiple imputation via chained equation (MICE), a 
mixed-effects model, a Gaussian process regression, and a multi-state model - for imputing 
cross-sectional GOSe at 6 months exploiting the longitudinal GOSe measurements. Each 





Materials and Methods 
Study population 
The CENTER-TBI project methods and design are described in detail elsewhere.14 Partici-
pants with TBI were recruited into three strata: (a) patients attending the emergency room, 
(b) patients admitted to hospital but not intensive care, and (c) patients admitted to intensive 
care. Follow-up of participants was scheduled per protocol at 2 weeks, 3 months, and 6 
months in group (a) and at 3 months, 6 months, and 12 months in groups (b) and (c). The 
protocol time window for the 6 months GOSe was between -1 and +2 months from the 6- 
months time point (5-8 months post injury). Outcome assessments at all timepoints included 
the GOSe. The GOSe has the following categories: (1) dead, (2) vegetative state, (3) lower 
severe disability, (4) upper severe disability, (5) lower moderate disability, (6) upper moder-
ate disability, (7) lower good recovery, (8) upper good recovery. The GOSe was collected 
using structured interviews15 and patient/carer questionnaires16. Since the latter does not 
identify vegetative patients as a separate category, the vegetative state and lower severe 
disability were combined in one group. 
 
The study population for this empirical methods comparison are all individuals from the 
CENTER-TBI database (total of n = 4509) whose GOSe status was recorded at least once 
within the first 18 months and who were still alive 180 days post-injury (n = 3343). The ra-
tionale for conducting the comparison conditional on 6-months survival is simply that the 
GOSe can only be missing at 6-months if the individuals are still alive since GOSe would be 
known to be “dead” otherwise. Data for the CENTER-TBI study were collected through the 
Quesgen electronic-case report form (Quesgen Systems Inc, USA), hosted on the Interna-
tional Neuroinformatics Coordinating Facility (INCF) platform and extracted via the INCF 
 
 
Neurobot tool (https://neurobot.incf.org/). Release 1.1 of the database was used (cf. Appen-
dix for details). Basic summary statistics for population characteristics are listed in Table 1. 
 
We decided to use only those GOSe observations obtained between injury and 18 months 
post injury, since extremely late follow-ups were considered uninformative for the index fol-
low-up time point of 6 months post injury. This led to a total of 8185 GOSe observations of 
the study population being available for the analyses. For 1151 (34%) individuals, GOSe ob-
servations at 180 +/- 14 days post injury were available and 2394 (72%) individuals had 
GOSe observations within the per-protocol window of 5-8 months post injury. The distribu-
tion of GOSe sampling times and both absolute and relative frequencies of the respective 
GOSe categories are shown in Figure 1. True observation times were mapped to categories 
by rounding to the closest time point, i.e., the ‘6 months’ category contains observations up 
to 9 months post-injury. Thus, the figures include a small proportion of GOSE 1 representing 
patients who died between 6 and 9 months. 
 
Figure 1: GOSe sampling time distribution and distribution at per-protocol time points 
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We compared LOCF to a MICE panel regression approach (MI), a mixed effect model (MM), 
a Gaussian process regression (GP), and a multi-state model (MSM). For all model-based 
approaches we additionally explored variants including the key IMPACT7 predictors as co-
variates. These are age, GCS motor score, pupil reactivity (0, 1, 2), hypoxia, hypotension, 
Marshall CT classification, traumatic subarachnoid hemorrhage, epidural hematoma, glu-
cose, and hemoglobin. 
 
Last-observation-carried-forward 
Since LOCF is widely used to impute missing outcomes in TBI studies,6,7,9 it served as the 
comparator method. Here, LOCF was defined as the last GOSe observation before the im-
putation time point of 180 days post-injury. LOCF is not a model-based method and, by defi-
nition, only permits the imputation of a GOSe value for subjects where at least one value 
was available within the first 180 days post injury. We accounted for this lack of complete 
coverage under LOCF by performing all performance comparisons including LOCF only on 
the subset of individuals for which a LOCF-imputed value can be obtained. 
Model-based methods 
Model-based imputation approaches offer richer output (probabilistic imputation, multiple im-
putation) and may reduce the LOCF-inherent bias. We compared the performance of four 
model-based approaches to that of LOCF.  
The MICE regression approach (MI) is a standard approach to multiple imputation that de-
fines regression models for each missing variable in a matrix.17 By iterating over each varia-
 
 
ble that contains missing values, and resampling missing values from the corresponding re-
gression model while holding all other variables fixed, a steady-state canultimately be 
reached, and a set of imputed datasets can be generated. Since our goal is single imputa-
tion, we reduced the set of imputed values to a prediction by taking the most frequently im-
puted GOSe value. The frequency distribution of the imputed GOSe values can be used as 
probabilistic prediction in very much the same way as the probabilistic output of other model-
based methods. To incorporate the longitudinal aspect of GOSe, we jointly imputed GOSe at 
2 weeks, 3 months, 6 months and 12 months jointly. This means that the GOSe at 2 weeks, 
3 months, and 12 months act as covariates in the regression model for the 6-months GOSe.  
Mixed effects models (MM) are a widely used approach in longitudinal data analysis and 
models individual deviations from the population mean trajectory. 18 The mixed effects model 
used for the GOSe imputation incorporates time as non-linear covariate via a spline to be 
able to capture non-linear dynamics of GOSe over time in the population. The mixed effects 
model was fitted using Bayesian methods to allow the inclusion of patient-specific quadratic 
random effect (see Appendix for details). An alternative non-linear regression model for lon-
gitudinal data is Gaussian process regression (GP) which allows flexible modelling of both 
the individual GOSE trajectories as well as the population mean in a Bayesian non-paramet-
ric way.19 Both the employed mixed effects model as well as the Gaussian process regres-
sion model are non-linear regression techniques for longitudinal data. While these are pow-
erful tools to model longitudinal trajectories, they do not explicitly model the probability of 
transitions between GOSe states. Since the number of observations per individual is limited 
in our data set (1 to 4 GOSe observations per individual), an approach explicitly modelling 
transition probabilities might be more suitable to capture the dynamics of the GOSe trajecto-
ries. To explore this further, a Markov multi-state model (MSM) was considered.20,21 
All models were fitted using either none or all IMPACT predictors except for the MSM model 
which only used age due to issues with numerical stability. Computational intensity is hard to 
compare since it depends on the exact hardware used. All methods except MSM can at 
least partially be run in parallel. On a Mac Book Pro 2019 the required time to fit each of the 
 
 
models on the entire available CENTER TBI data (with IMPACT covariates) was 13 minutes 
(MI), 26 minutes (MSM), 86 minutes (MM), and 112 minutes (GP). Although these differ-
ences are substantial, they are within one order of magnitude and would not preclude any of 
the methods in practice. Further details on the implementations are given in the Appendix. 
All models, irrespective of the fact whether they are Bayesian or frequentist, produce proba-
bilistic outputs, i.e., a discrete probability distribution over the possible GOSe values at 6 
months for each individual. Although we propose only to store these probabilities along with 
the most likely GOSe value at 6 months, multiple imputations can be obtained post-hoc by 
resampling from the discrete probability distribution of each individual via inverse transform 
sampling.22 The functions required to sample from a discrete probability distribution are 
available in any statistical software package. 
All four model-based approaches allow unbiased inference under a ‘missing at random’ 
(MAR) mechanism 23 Here, MAR means that the fact whether or not a GOSe observation is 
missing is independent of the true functional outcome status of the individual. GOSe is an 
interview-based assessment that can also be completed by a proxy. The main operational 
challenge for consistent collection of longitudinal GOSe for observational studies thus lies in 
the organisation and scheduling of the interviews. A MAR assumption for CENTER data was 
thus deemed plausible, albeit is not testable.23 
 
Performance assessment 
Model performance was assessed via three-fold cross validation on the subset of individuals 
with a valid GOSe value within 180 +/- 14 days post-injury (n = 1083). All models were fit on 
the entire available data after removing the 180 +/- 14 days post-injury observation from the 
respective test fold thus mimicking a missing completely at random missing data mecha-
nism. The distribution of GOSe values in the three test sets was well balanced, (cf. Appen-
dix, Figure A.1). All confusion matrices are reported as averages over the three-fold cross 
 
 
validation test sets. The column fraction confusion matrices are normalized within each cate-
gory of observed GOSe value and are thus estimates of confusion probability conditional on 
the observed GOSe. Performance was assessed using the absolute-count and the normal-
ized (proportions) confusion matrices as well as bias, mean absolute error (MAE), and root 
mean squared error (RMSE). Bias is calculated by averaging the signed differences be-
tween observed and imputed values.  A negative value of bias signifies that predicted values 
are lower overall than observed values, and a positive value means that they are higher. If 
differences cancel each other out then bias can be zero even if the the predictions are inac-
curate. MAE employs the unsigned differences, and it therefore gives a measure of accuracy 
irrespective of whether imputed outcomes are higher or lower than observed. In the calcula-
tion of RMSE the differences are squared, which penalizes large deviations from the target 
value more strongly than small ones.  For example, the MAE will be 0.5 if 50% of imputed 
values agree with observed values and 50% differ by one category. The same MAE will 
arise if 75% agree exactly and 25% disagree by two categories. In the former case the 
RMSE will be 0.71 and in the latter 1.0. 
These metrics have some limitations with ordinal data, and we therefore also considered di-
rectional bias (d-bias), which was calculated as the difference between the model-fitted 
probability of exceeding the observed value minus the model-fitted probability of undershoot-
ing the observed GOSe as an alternative measure of bias. It is important to note that the 
scale of the directional bias is not directly comparable to the one of the other three quanti-
ties. All measures were calculated in the dataset that was conditional on the ground-truth 
(observed 6-months GOSe) as well as averaged over the entire test set. 
LOCF, by design, cannot provide imputed values when there are no observations before 180 
days post injury. A valid comparison of LOCF with the other methods must therefore be 
based on the set of individuals for whom an LOCF imputation is possible. Overall, 118 out of 
1083 test cases (10.9%) could not be imputed with the LOCF approach. In the entire study 
population, 345 individuals (10.3%) did not have data that would permit an LOCF imputation. 
 
 
The subset used for comparison of the imputation approaches with the LOCF approach was 





The overall performance of all fitted models in terms of bias, d-bias, MAE, and RMSE is de-
picted in Figure 2 both conditional on LOCF being applicable (gray) and, excluding LOCF, 
on the entire test set (black). Values are reported as mean over the three cross-validation 
folds and error bars indicate +/- 1.96 standard errors. 
 
Figure 2: Cross-validated overall performance for all fitted models on the LOCF sub-
set (allowing LOCF) and the entire test set (LOCF performance not shown). 
 
Several key findings are worth highlighting. Firstly, LOCF is overall negatively biased, i.e., on 
average it imputes lower-than-observed GOSe values. This reflects a population average 
trend towards continued recovery within the first 6 months post injury. The fact that both 
ways of measuring bias qualitatively agree, suggests that application of these metrics is rea-
sonable for the data. In terms of MAE and RMSE, LOCF also has worst performance, but 
differences between methods are less pronounced than for measures of bias. Notably, the 
RMSE difference between LOCF and the other methods is slightly larger than the MAE dif-
ference which indicates that LOCF tends to produce more large deviations, i.e., across sev-
eral GOSe categories. 
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Second, including baseline covariates only produces clinically meaningful impact in the case 
of the GP regression model. The MI, MM, and MSM models perform more or less the same 
irrespective of adjustment for baseline covariates. This indicates that the additional predic-
tive value of baseline covariates over the information contained in at least one observed 
GOSe value is limited. Furthermore, both variants of the MI model and the mixed effects 
model fail to correct the overall bias of the imputed values. 
We proceed with a detailed analysis of a subset of models both in direct comparison with 
LOCF and in the entire data set including those cases where LOCF is not applicable. In the 
following we only consider the baseline-adjusted Gaussian process model (‘GP + cov’), the 
MI model without baseline covariates, the mixed effect model without baseline covariates 
(‘MM’), and the multi-state model without baseline covariates (‘MSM’). The rationale behind 
dropping baseline adjustment for MI, MM, and MSM being that the additional complexity 
does not substantially alter overall performance. On the other hand, the GP model benefits 
from the inclusion of the IMPACT baseline covariates. 
Detailed comparison conditional on LOCF subset 
We first consider the results for the set of test cases which allow LOCF imputation (n = 965). 
Both the raw count as well as the relative (by left-out observed GOSe) confusion matrices 
are presented in Figure 3. The GOSe scale is restricted to 3+ since the imputation is condi-
tional on an observed GOSe larger than 1 (deaths are known and no imputation necessary) 





Figure 3: Confusion matrices averaged across folds (LOCF subset only); absolute 
counts. Note that imputation is carried out with the relevant observed values (test set) 
of the GOSe removed 
 
The absolute-count confusion matrices show that most imputed values are within +/- one 
GOSE categories of the observed ones and this yields an RMSE of approximately 1. How-
ever, they also reflect the category imbalance (cf. Figures 1) in the study population. The 
performance conditional on the (in practice removed) observed GOSe value clearly shows 
that imputation for the most infrequent category 4 is hardest. This is true across the range of 
methods considered. Both the MSM and the MM models account for this difficulty by almost 
never imputing a GOSe of 4. Instead, the respective cases tend to be imputed to GOSe 3 or 
5. 
 
To better understand the overall performance assessment in Figure 2, we also consider the 
performance conditional on the respective ground-truth (i.e. the observed GOSe categories 
in the test sets). The results are shown in Figure 4 (vertical bars are +/-1.96 standard error of 
the mean). 
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Figure 4: Performance measures by observed GOSe; LOCF subset only. 
 
Just as with overall performance, differences are most pronounced in terms of bias. Interest-
ingly, the assessment conditional on LOCF being feasible reveals differences between bias 
as the difference between mean imputed and mean observed values and the difference in 
the probability to over- or undershoot the observed value. Again, the category imbalance in 
the GOSe distribution explains the fact that all model-based approaches tend to perform bet-
ter for the most frequent categories 6, 7, and 8 while sacrificing performance for the less fre-
quent categories 4 and 5 as compared to LOCF. With respect to bias, all methods exhibit a 
certain regression to the mean effect since low categories tend to be confused with better 
(higher) GOSe on average while high observed GOSe values are subject to a negative bias 
(at GOSe 7 and 8). Since LOCF does not take the category imbalance into account and 
since it exhibits a relatively large negative bias at the most frequent GOSe values, it is over-
all negatively biased. The conditional assessment of the GP regressions bias profile reveals 
overall unbiasedness, but this is the consequence of the relatively high positive and negative 
biases conditional on low/high GOSe values canceling each other out in the overall popula-
tion. The MI, MSM, and MM models are fairly similar with respect to accuracy but MSM 
clearly dominates with respect to bias. Note that irrespective of the exact definition of bias 
bias dïbias MAE RMSE








MSM GP + cov MM LOCF
Summary measures by observed GOSe, LOCF subset
 
 
used, MSM dominates the other model-based approaches. Comparing LOCF and MSM, 
there is a slight advantage of MSM in terms of accuracy for the majority classes 3, 7, 8 
which explain the overall difference shown in Figure 2. With respect to bias, MSM also per-
forms better than LOCF for the most frequently observed categories, but the extent of this 
improvement depends on the performance measure. 
 
Detailed comparison on full test set 
LOCF was not considered in the analysis of the full dataset, since no LOCF was available 
for subjects with a first recorded outcome assessment more than six months post-TBI, and 
this renders a meaningful comparison across the entire dataset impossible. The qualitative 
performance of the three remaining imputation approaches in the complete dataset was sim-




Figure 5: Confusion matrices averaged across folds (entire test set, no LOCF); abso-
lute counts. Note that imputation is carried out with the relevant observed values (test 
set) of the GOSe removed. 
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Handling missing data post-hoc to mitigate biases in analyses often requires great effort. It is 
thus of the utmost importance to implement measures for avoiding missing data in the first 
place. Nevertheless, in practice, missing values due to loss-to-follow-up will always occur 
and should be addressed effectively.3 There is a wide consensus that statistically sound im-
putation of missing values is beneficial for both the reduction of bias and for increasing sta-
tistical power. The current gold-standard for imputing missing values is multiple imputation 
on a per-analysis basis, including analysis-specific covariates to further reduce bias and to 
preserve the imputation uncertainty in the downstream analysis. In practice, however, there 
are good reasons for providing a set of single-imputed default values in large observational 
studies such as CENTER-TBI. CENTER-TBI is committed to providing a curated database 
to facilitate multiple subsequent analyses. Since one of the primary endpoints in CENTER-
bias dïbias MAE RMSE
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TBI is functional outcome at 6 months, a single default imputed value for as many study par-
ticipants as possible is desirable. Consortia are increasingly committed to making their data-
bases available to a range of researchers. In fact, more liberal data-sharing policies are be-
coming a core requirement for funding bodies (cf. https://www.openaire.eu/). In this context, 
it might not be possible to ensure that every analysis team has the necessary statistical ex-
pertise to properly conduct a per-analysis multiple imputation in the future. Furthermore, the 
imputed values of a multiple-imputation procedure are inherently random, and it is thus diffi-
cult to ensure consistency across different analysis teams if the values themselves cannot 
be stored directly in a database. For this reason, as a practical way forward, we suggest 
providing a default single-imputation together with a predictive distribution (value probabili-
ties) for key outcomes in the published data base itself. This mitigates problems with com-
plete-case analyses and provides a principled and consistent default approach to handling 
missing values. Given the strong case for employing model-based approaches to imputation, 
it makes good sense to provide the predicted probabilities for each GOSe outcome in the 
core database alongside single imputed values as a transparent method for quantifying con-
fidence in the imputation prediction. Based on these probabilities, it is easy to draw samples 
for a multiple imputation analysis if needed. Since we did not find any of the common predic-
tors of GOSe to have substantial effect on the imputed values in the presence of at least one 
observed GOSe value (at another timepoint than 6 months), the imputed values can be used 
in a wide range of subsequent analyses.  
Wherever necessary and practical, a custom, analysis-specific multiple imputation approach 
might still be employed. In these cases, the model providing the single-imputed values may 
be used as a starting point. 
 
Several reasons disqualify LOCF as method of choice. Not only is it inherently biased, but it 
is also inefficient in that it fails to properly account for the category imbalance of GOSe in the 
respective target population. Albeit simple to implement, LOCF - by definition - is not capa-
ble of exploiting longitudinal information obtained after the target time point. This results in a 
 
 
smaller subset of individuals for which imputed values can be provided in the first place. 
LOCF also lacks flexibility to adjust for further covariates which might be necessary in some 
cases to further reduce bias under a missing at random assumption. Finally, LOCF cannot 
produce an adequate measure of imputation uncertainty, since it is not model based. 
Given this context, we draw two main conclusions from our comparison of three alternative, 
model-based approaches.  
 
First and despite its theoretical drawbacks, LOCF is hard to beat in terms of accuracy (both 
MAE and RMSE). The main advantages of a model-based approach are thus the ability to 
impute values for the entire study population, the reduction of bias, the ability to provide a 
measure of uncertainty (value probabilities) together with the imputed values (or to use the 
same very same model to draw multiple imputations), as well as the possibility of including 
further analysis-specific covariates. 
 
Second, we found that the inclusion of established baseline predictors had little effect on the 
imputation quality. Note that this does not refute their predictive value, and the IMPACT co-
variates may be more relevant in studies confined to moderate and severe injuries. How-
ever, the current study suggests that there is little added benefit once at least one GOSe 
value is known. Differences between the various model-based approaches are rather nu-
anced. The more complex longitudinal models (GP, MM) that where fitted using Bayesian 
methods did not perform better and due to the inherent complexities of a Bayesian analyses 
(e.g., convergence assessment) we discourage their use for the specific application at hand. 
The more standard MI-based approached achieved similar performance to the MSM ap-
proach in terms of precision (MAE or RMSE) but did not remove bias completely. We thus 
favour the multi-state model (MSM) for several reasons. It is well-interpretable in terms of 
transition intensities, and an efficient implementation is available21 in standard statistical soft-
ware.24 Finally, it is the only method considered here that succeeds in eliminating the bias 
observed with LOCF. As all other model-based imputation methods, MSM is able to provide 
 
 
imputed values for the entire population and to provide a probabilistic output to quantify im-
putation uncertainty.  
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Appendix / Supplemental Material 
Ethical approval statement 
The CENTER-TBI study (EC grant 602150) has been conducted in accordance with all rele-
vant laws of the EU if directly applicable or of direct effect and all relevant laws of the coun-
try where the Recruiting sites were located, including but not limited to, the relevant privacy 
and data protection laws and regulations (the “Privacy Law”), the relevant laws and regula-
tions on the use of human materials, and all relevant guidance relating to clinical studies 
from time to time in force including, but not limited to, the ICH Harmonised Tripartite Guide-
line for Good Clinical Practice (CPMP/ICH/135/95) (“ICH GCP”) and the World Medical As-
sociation Declaration of Helsinki entitled “Ethical Principles for Medical Research Involving 
Human Subjects”. Informed Consent by the patients and/or the legal representative/next of 
kin was obtained, accordingly to the local legislation, for all patients recruited in the Core Da-
taset of CENTER-TBI and documented in the e-CRF. Ethical approval was obtained for each 
recruiting site. The list of sites, Ethical Committees, approval numbers and approval dates 
can be found on the website: https://www.center-tbi.eu/project/ethical-approval. 








Multiple imputation via chained equations (MICE) is a standard approach to multiple imputa-
tion.17 Instead of specifying a full (longitudinal) model for GOSe the MI approach uses a so 
called “fully conditional approach” to specify a model for each variable in a dataset given all 
other variables. By sequentially refitting these conditional models and then resampling miss-
ing values a set of imputed datasets can be generated. For the GOSe prediction, we treated 
the GOSe at the nominal query points of two weeks, 3 months, 6 months, and 12 months as 
separate variables and imputed them using the mice package for the R programming lan-
guage.24 We used proportional odds ordinal regression 25 as conditional models for the ordi-
nal outcome GOSe at the four different time points and ran the algorithm with 100 chains up 
to convergence. This means that 100 potential GOSe outcomes per individual with missing 
GOSe at 6 months are available upon convergence of the procedure. The final probabilistic 
1 2 3








predictions where then taken as the relative frequencies of the imputed outcomes and the 
point prediction as the most frequently imputed value.  
 
Mixed-effects model 
Mixed effects models are a widely used approach in longitudinal data analysis and model in-
dividual deviations from a population mean trajectory.18 To account for the fact that the 
GOSe outcome is an ordered factor, we employ a cumulative link function model with flexi-
ble intercepts.25 The population mean is modeled as a cubic spline function to allow a non-
linear population mean trajectory. Patient-individual deviations from this population mean are 
modeled as quadratic polynomials to allow sufficient flexibility (random effects). Baseline co-
variates are added as linear fixed effects to the population mean. The model was fitted using 
Bayesian statistics via the BRMS package26,27 for the R environment for statistical compu-
ting24 and the Stan modelling language for Markov Chain Monte Carlo sampling.28 The re-
quired burn-in length to reach a steady state for the Markov Chains was determined by in-
specting the trace plot of the model on the complete data set. During the cross validation fits 
the same burn-in length was used and convergence was assessed via the potential scale 
reduction factor (PSRF) proposed by Gelman and Rubin.29 A Bayesian approach was nec-
essary since the quadratic random effect is not identifiable in individuals where only one or 
two GOSe values are available. The model with cubic spline fixed effect for time and quad-
ratic random effects for time per individual was selected based on the highest expected log 
predictive density on the full data set (computed via the loo package30, data not shown). 
Non-informative priors were used for the model parameters. These are sufficient to make all 
model parameter identifiable and effectively shrink the quadratic random effect in individuals 
with only two observed GOSe values to zero. A potential drawback of the proposed longitu-
dinal mixed effects model is the fact that the individual deviations from the population mean 
are modeled globally using polynomials. Since linear and quadratic terms are not identifiable 
 
 
for patients with only one observed GOSE value, this implies large uncertainty over the pa-
tient-specific effects for individuals with one or two observations only by falling back on the 
non-informative priors on these model parameters. Thus, the overall uncertainty associated 
with model-based imputations at exactly 180 days may become relatively large for these in-
dividuals. A more flexible regression model might avoid this particular pathology which is 
why we also implement a Gaussian process regression model (see below). 
Gaussian process model 
Gaussian process regression allows flexible modelling of both the individual GOSE trajecto-
ries as well as the population mean in a Bayesian non-parametric way.19 This non-paramet-
ric paradigm leads to low model-uncertainty in the vicinity of actually observed GOSe out-
comes. To account for the discreteness of the GOSe outcome, the continuous output of the 
Gaussian process model is rounded to the nearest integer in 1 to 8 (GOSe categories). The 
squared exponential covariance function with shared length scale for all individuals is used 
to model intra-individual dependency of GOSe outcomes. The population mean trajectory of 
the Gaussian process is modeled as mean of an independent Gaussian process with 
pseudo observations at 45, 90, 180, 270, 360 days post-injury (also using a squared expo-
nential covariance function). This approach maintains flexibility of the population mean func-
tion similar to the spline-based approach for the mixed effects model while avoiding the com-
putational complexity of a fully hierarchical Gaussian process model. Again, the impact of 
baseline covariates is modeled via linear effects on the population mean of the Gaussian 
process. All parameters are estimated in a fully Bayesian fashion using the Stan modelling 
language28 and non-informative priors except for the length scale of the squared exponential 
kernel. Due to the sparseness of the data, the estimated length scale will naturally tend to-
wards extremely large values implying unrealistically long-range dependency between ob-
servations. We therefore limit the length scale to a maximum of 120 days (4 months) and im-





Both the mixed effects model as well as the Gaussian process regression model are essen-
tially non-linear regression techniques for longitudinal data. While they are both powerful 
tools to model longitudinal trajectories, they do not explicitly model the probability of transi-
tions between GOSe states. Since the number of observations per individual is limited in our 
data set (1 to 4 GOSe observations per individual), an approach explicitly modelling transi-
tion probabilities might be more suitable to capture the dynamics of the GOSe trajectories. 
To explore this further, a Markov multi-state model is considered.20 This model class as-
sumes that the transitions between adjacent GOSe states can be modeled as a Markov pro-
cess and the transition intensities between adjacent states are fitted to the observed data. 
 
Figure A.2: Structural diagram of allowed transitions between GOSe states for the 
proposed multi-state model. 
 
To account for the fact that state-transitions might be more frequent in the early post-injury 
phase, piecewise constant transition intensities were fitted to the intervals [0, 90), [90, 270), 
and 270+ days post-injury. The model was fit using the msm package21 for the R environ-
ment for statistical computing.24 Due to the relatively large number of 19 transition intensities 
in the proposed model (cf. arrows in Figure A.1, structure of transition graph), inclusion of all 
baseline covariates turned out to be numerically unstable. For the MSM model, instead of 
1
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including all covariates, only a model adjusting for age at injury via a proportional hazard ap-




Reproducible Research Strategy 
CENTER-TBI is committed to reproducible research. To this end, the entire source code to 
run the analyses is publicly available at https://git.center-tbi.eu/kunzmann/gose-6mo-imputa-
tion. Scripts for automatically downloading the required data from the central access re-
stricted ‘Neurobot’ (https://neurobot.incf.org/) database at https://center-tbi.incf.org/ are pro-
vided. The analysis is completely automated using the workflow management tool ‘snake-
make31 and a singularity32 container image containing all required dependencies is publicly 
available from zenodo.org (DOI: 10.5281/zenodo.2600385). Detailed step-by-step instruc-
tions on how to reproduce the analysis are provided in the README.md file of the GitLab 
repository. 
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Table 1: Baseline descriptive variables stratified by applicability of LOCF; LOCF is not 
applicable when no GOSe observation prior to 180 days is available. N is the number 
of non-missing values. P values are based on the Chi-squared test for binary varia-
bles and on the Wilcoxon test for continuous variables. 
 
 N  no LOCF possible (N=118) LOCF possible (N=3225)  
Age 3343    P=0.46 
        Median (interquartile range)   47.0 (29.0—61.1) 49.0 (29.0—64.0)  
        Range   7.0—90.0 0.0—95.0  
Sex: Male 3343 65/118 (55.085) 2145/3225 (66.512) P=0.01 
Stratum 3343   P=0.87 
        Emergency Room   22/118 (18.644) 664/3225 (20.589)  
        Admission to 
Hospital 
  43/118 (36.441) 1155/3225 (35.814)  
        Intensive Care 
Unit 
  53/118 (44.915) 1406/3225 (43.597)  
Cause of Injury 3334    P=0.11 
        Road traffic incident   57/118 (48.305) 1250/3216 (38.868)  
        Incidental fall   38/118 (32.203) 1440/3216 (44.776)  
        Other   14/118 (11.864) 316/3216 (9.826)  
        Violence/assault   7/118 (5.932) 146/3216 (4.540)  
        Unknown   2/118 (1.695) 64/3216 (1.990)  
ISS, total 3305   P=0.39 
        Median (interquartile range)   16 (9—27) 16 (9—26)  
        Range   1—75 1—75  
GCS 3236   P=0.62 
        Mild   82/115 (71.304) 2297/3121 (73.598)  
        Moderate   8/115 (6.957) 252/3121 (8.074)  
        Severe   25/115 (21.739) 572/3121 (18.327)  
Marshall CT 3030   P=0.87 
        1   49/106 (46.2264) 1206/2924 (41.2449)  
        2   40/106 (37.7358) 1230/2924 (42.0657)  
        3   3/106 (2.8302) 82/2924 (2.8044)  
        4   0/106 (0.0000) 16/2924 (0.5472)  
        5   0/106 (0.0000) 6/2924 (0.2052)  
        6   14/106 (13.2075) 384/2924 (13.1327)  
Subarachnoid Hematoma: yes 3262 41/115 (35.652) 1131/3147 (35.939) P=0.95 
Extradural Hematoma: yes 3243 7/113 (6.1947) 356/3130 (11.3738)  P=0.09 
Hypoxia: yes 3167 7/109 (6.4220) 170/3058 (5.5592) P=0.70 
Hypotension: yes 3193 6/110 (5.4545) 178/3083 (5.7736) P=0.89 
Glucose [mmol/L] 2548   P=0.90 
        Median (interquartile range)   6.8 (5.9—8.3) 6.9 (5.9—8.2)  
        Range   3.7—15.7 1.9—33.5  
Hemoglobin [g/dL] 2802   P=0.67 
        Median (interquartile range)   13.6 (12.4—14.6) 13.5 (12.0—14.6)  
        Range   8.1—17.1 1.3—23.4  
 
